anaveon
  • About
    • Our Journey
    • About Us
    • Anaveon In Depth
  • Science
    • Our Approach
    • Publications
  • Team
    • Our Team
    • Our Board
    • Our Investors
  • News
  • Career
  • Contact Us
Select Page
HomeApril
Anaveon presents ANV600, a novel development compound, at the 2023 American Association for Cancer Research Annual Meeting

Anaveon presents ANV600, a novel development compound, at the 2023 American Association for Cancer Research Annual Meeting

by marketing@seuss.plus | Apr 18, 2023 | Uncategorized

DOWNLOAD POSTER...

Search here

Categories

  • Press Releases 19
  • Uncategorized 4

Recent Posts

  • Anaveon presents clinical trial OMNIA-2 at the American Society of Clinical Oncology 2023 Annual Meeting
    June 5, 2023
  • Anaveon Presents Trial in Progress Data for OMNIA-1 at the American Society of Clinical Oncology 2023 Annual Meeting
    June 3, 2023
  • Anaveon presents ANV600, a novel development compound, at the 2023 American Association for Cancer Research Annual Meeting
    April 18, 2023

We are social

Popular Tags

#ANV419 #ESMO22 #phaseI/II 2020 AACR Annual Meeting anaveon brand clinical data CTA approval First patient investment news phase I phase I/II study phase II presentation press solid tumors start trial study data team website

Archives

  • June 2023  2
  • April 2023  1
  • March 2023  2
  • February 2023  1
  • November 2022  2
  • October 2022  1
  • September 2022  1
  • July 2022  3
  • April 2022  1
  • March 2022  1
  • December 2021  1
  • November 2021  1
  • June 2021  1
  • March 2021  1
  • November 2020  1
  • May 2020  1
  • April 2019  1
  • February 2019  1
Anaveon_ submark

Contact us

Email

contact@anaveon.com

Postal Address

Anaveon AG

Technologiepark Basel

Hochbergerstrasse 60C

4057 Basel

Switzerland

Follow us

  • Linkedin
  • Home
  • Privacy Policy
  • Photography Credit

© 2020 All Rights Reserved